Sanofi-aventis acquires controlling stake in Shantha

The French pharmaceuticals company agrees to an aggressive valuation of $784 million to buy control of the Hyderabad-based biotechnology firm from Merieux Alliance.

To continue reading, please login or register for free

Print Edition

FinanceAsia Print Edition

CONFERENCES